Funding for this research was provided by:
Health Resources and Services Administration (U91HA06801, U91HA06801, U91HA06801, U91HA06801, U91HA06801, U91HA06801)
Received: 23 October 2022
Accepted: 26 April 2023
First Online: 5 May 2023
: The UW Subjects Division (#STUDY00013565) and the CDC Science Integrity Branch (#CGH-HIVPKP-4/14/21-f6e6a) reviewed and approved the study protocol as a program evaluation with minimal risk to human subjects. The Institutional Review Board of the Public Health Center of the Ukraine Ministry of Health waived off the need to provide a formal review of the study protocol, based upon it being a program evaluation with minimal risk to human subjects. Both the University of Washington Human Subjects Division and the CDC Science Integrity Branch waived off the need for informed consent from study participants, based on the secondary use of routinely collected, deidentified client data. There were no experiments performed as part of the study, and all study procedures were performed in accordance with the Declaration of Helsinki and other relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.